Compare LSAK & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSAK | SGHT |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.8M | 489.7M |
| IPO Year | 2005 | 2021 |
| Metric | LSAK | SGHT |
|---|---|---|
| Price | $4.00 | $9.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.17 |
| AVG Volume (30 Days) | 228.8K | ★ 313.7K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.63 | 28.16 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $721,554,000.00 | $77,363,000.00 |
| Revenue This Year | $11.77 | $16.75 |
| Revenue Next Year | $13.46 | $11.78 |
| P/E Ratio | $136.33 | ★ N/A |
| Revenue Growth | ★ 9.38 | N/A |
| 52 Week Low | $3.62 | $3.38 |
| 52 Week High | $5.54 | $9.71 |
| Indicator | LSAK | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 34.23 | 59.30 |
| Support Level | N/A | $7.88 |
| Resistance Level | $4.94 | $9.71 |
| Average True Range (ATR) | 0.20 | 0.46 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 2.83 | 81.92 |
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.